G
Guest
http://www.reuters.com/article/us-boston-scientific-recall-idUSKBN1621NA
Boston Scientific Corp said on Thursday it was recalling its Lotus range of heart devices, citing reports of problems with the locking mechanism, sending its shares down as much as 7.4 percent.
The company also delayed the submission of its U.S. marketing application for its keenly anticipated Lotus Edge device, giving its rivals an edge in the transcatheter aortic valve replacement (TAVR) market.
Boston Scientific's Lotus technology is used in TAVR, a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly.
Boston Scientific Corp said on Thursday it was recalling its Lotus range of heart devices, citing reports of problems with the locking mechanism, sending its shares down as much as 7.4 percent.
The company also delayed the submission of its U.S. marketing application for its keenly anticipated Lotus Edge device, giving its rivals an edge in the transcatheter aortic valve replacement (TAVR) market.
Boston Scientific's Lotus technology is used in TAVR, a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly.
